Related Articles
Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer
Chemokine CCL20 promotes the paclitaxel resistance of CD44<sup>+</sup>CD117<sup>+</sup> cells via the Notch1 signaling pathway in ovarian cancer
Carboplatin treatment of antiestrogen-resistant breast cancer cells
The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines
Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer